The Food and Drug Administration (FDA) conducted an inspection at Therapak Corporation in Claremont on Feb. 12 regarding project evaluation for devices, according to information published on the FDA’s website.
The inspection’s final report recommended that Therapak Corporation take voluntary steps to address the management of its operations.
Across the country, the FDA carries out regular inspections at facilities to determine whether the workplaces and their products meet laws and regulations aimed at protecting public health. Inspection outcomes are subsequently made available to the public.
The agency’s website states that the FDA is responsible for overseeing the safety and quality of human and animal drugs, biologics, medical products, and tobacco items.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
